RxDoctor Payments Data

Ratna Kunasani, MD

Vascular Surgery · Greenbelt, MDNPI 1104073808

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (55.3%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 11 manufacturers reported payments, led by Silk Road Medical, Inc. at 38.1% of the total. Reporting peaked in 2019 at $1,627 and has fallen 88.7% since, to $184 in 2025. That places this record below the midpoint for vascular surgery clinicians in MD, where the typical reported total is $3,095.

$3,260in general payments, 2019–2025

Across 31 payments — averaging $105.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Silk Road Medical, Inc.$1K
  • Cook Medical LLC$712
  • KCI USA, Inc.$486
  • Cook Incorporated$353
  • Boston Scientific$143
  • Abbott$126
  • plus $197 from 5 others

What the payments were for

  • Consulting fees$40012%
  • Travel & lodging$1,80255%
  • Food & beverage$1,05832%

General payments by program year

19
20
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,260 in reported general payments places this provider in the 50th percentile of 104 vascular surgery providers in Maryland.

See all vascular surgery providers in Maryland

Medicare billing

Part B allowed, 2024
$44,081
Medicare patients
154
Services billed
361

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ClopidogrelClopidogrel Bisulfate34$368

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Greenbelt

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →